The Diagnostic Value of Serum Glypican-3 in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Journal Title: International Journal of Health & Medical Research - Year 2023, Vol 2, Issue 09
Abstract
Background and aim: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. It is curable in the early stages but has a poor prognosis when advanced. Current diagnostic protocols for the early stages of HCC are inefficient. Serum Glypican-3 (GPC-3) is a promising serum tumour marker in diagnosing HCC, and its diagnostic value has been explored in various studies. The outcomes, however, continue to be inconsistent and controversial. This systematic review and meta-analysis aimed to investigate the diagnostic accuracy of serum GPC-3 in hepatocellular carcinoma. This study included recent papers not captured in previous meta-analyses. Method: PUBMED, MEDLINE, Cochrane Library, and CINAHL databases were systematically searched according to preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies guidelines. Studies on the diagnostic accuracy of serum GPC-3 in HCC were selected. The Quality assessment of diagnostic accuracy studies 2 (QUADAS-2) tools were used to assess the quality of selected studies. Sensitivity, specificity, and other diagnostic parameters were pooled using the random effect model. The Summary receiver operating characteristic (sROC) was used to summarise the diagnostic accuracy of Serum GPC-3. Results: Eleven studies were included in this systematic review. The pooled sensitivity, specificity, and 95% confidence intervals (CIs) were 0.60 (0.57-0.62) and 0.67(0.64-0.70), respectively. The pooled positive and negative likelihood ratios and 95% CIs were 2.11 (1.51-2.93) and 0.59 (0.51-0.68), respectively; the pooled diagnostic odds ratio and the 95% CI were 4.07 (2.37-6.98), the area under the sROC curve was 0.7194. Conclusion: This meta-analysis has shown that Serum GPC-3 has an acceptable diagnostic value in diagnosing HCC compared to benign chronic liver diseases. A higher-quality study with a larger sample size is necessary to thoroughly assess the diagnostic utility of serum GPC-3.
Authors and Affiliations
Arinze I. Aninworie, MD, MSc
Keywords
Related Articles
- EP ID EP731145
- DOI 10.58806/ijhmr.2023.v2i9n05
- Views 23
- Downloads 0
Rheology of Hyaluronic Acid Dermal Fillers: Understanding the Science to Improve Results in Clinical Practice
Hyaluronic acid fillers are one of the most frequently used in cosmetic procedures. They are popular because of their ability to restore volume to the face, which surgery isn’t capable of. Inside the skin, the implant i...
Parotid Abscess in Young Adult: Case Report
Parotid abscess is a rare pathology in maxillofacial. In some countries, it occurs in elderly patients and patients with history of oral sepsis. A-25-years-old male patient came to the Oral and Maxillofacial Surgery Cli...
A Review of on the Psychobiological Differences among Tetrahydrocannabinol, Cannabinol, Cannabidiol and Cannabigerol
The endocannabinoid system plays a physiological natural anti-infiammatory anticancer role and the pharmacological effects of cannabinoids from Cannabis plant simply reflect the action of the endogenous ones. Therefore,...
Isolation And Identification Of Staphylococcus Aureus And Candida SPP From Throat Infections
This research aimed to isolate and identify Staphylococcus aureus and Candida species from throat infections, as well as assess their antibiotic resistance. Samples were collected from both infected patients and healthy...
Assessment of the Effect of Menopause on Thyroid Function in South East, Nigeria
Menopause marks the end of a woman’s reproductive life and is associated with significant physiological changes. The thyroid gland plays an important role in regulating overall body metabolism including sexual developme...